Range
23.65 - 27.95
Vol / Avg.
172.4K/267.6K
Div / Yield
-
52 Wk
12.6 - 28.78
Mkt Cap
1.2B
Payout Ratio
-
Open
26.88
P/E
-
EPS
-0.73
Shares
47.5M
Outstanding
47.5M
Total Float
37.1M
load more
Sector: Health Care.Industry: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidates include paltusotine which is in clinical development for the treatment of acromegaly and neuroendocrine tumors, or NETs, CRN04777, which is in clinical development for congenital hyperinsulinism, or HI, and CRN04894, which is in clinical development for diseases of excess adrenocorticotrophic hormone, or ACTH, including Cushing's Disease, congenital adrenal hyperplasia, or CAH, and Ectopic ACTH Syndrome, or EAS.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS-0.700-0.730 -0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Crinetics Pharmaceuticals Questions & Anwsers

Q

How do I buy Crinetics Pharmaceuticals (CRNX) stock?

A

You can purchase shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Crinetics Pharmaceuticals's (CRNX) competitors?

Q

What is the target price for Crinetics Pharmaceuticals (CRNX) stock?

A

The latest price target for Crinetics Pharmaceuticals (NASDAQ: CRNX) was reported by Evercore ISI Group on November 23, 2021. The analyst firm set a price target for 68.00 expecting CRNX to rise to within 12 months (a possible 178.69% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Crinetics Pharmaceuticals (CRNX)?

A

The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $24.4 last updated Fri Nov 26 2021 18:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Crinetics Pharmaceuticals (CRNX) pay a dividend?

A

There are no upcoming dividends for Crinetics Pharmaceuticals.

Q

When is Crinetics Pharmaceuticals (NASDAQ:CRNX) reporting earnings?

A

Crinetics Pharmaceuticals’s $Q3 earnings are confirmed for after-market on November 5, 2021.

Q

Is Crinetics Pharmaceuticals (CRNX) going to split?

A

There is no upcoming split for Crinetics Pharmaceuticals.

Q

What sector and industry does Crinetics Pharmaceuticals (CRNX) operate in?

A

Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.